Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Non-Current Assets (2022 - 2025)

Historic Non-Current Assets for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $3.1 million.

  • TriSalus Life Sciences' Non-Current Assets fell 1455.44% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year decrease of 2045.44%. This contributed to the annual value of $3.3 million for FY2024, which is 1161.67% down from last year.
  • TriSalus Life Sciences' Non-Current Assets amounted to $3.1 million in Q3 2025, which was down 1455.44% from $3.2 million recorded in Q2 2025.
  • TriSalus Life Sciences' Non-Current Assets' 5-year high stood at $251.0 million during Q3 2022, with a 5-year trough of $3.1 million in Q3 2025.
  • Its 4-year average for Non-Current Assets is $54.8 million, with a median of $4.5 million in 2023.
  • As far as peak fluctuations go, TriSalus Life Sciences' Non-Current Assets crashed by 9820.21% in 2023, and later plummeted by 1161.67% in 2024.
  • Over the past 4 years, TriSalus Life Sciences' Non-Current Assets (Quarter) stood at $4.8 million in 2022, then decreased by 21.86% to $3.7 million in 2023, then decreased by 11.62% to $3.3 million in 2024, then dropped by 5.06% to $3.1 million in 2025.
  • Its Non-Current Assets was $3.1 million in Q3 2025, compared to $3.2 million in Q2 2025 and $3.5 million in Q1 2025.